Intramuscular DNA immunization with in vivo electroporation induces antigen-specific cellular and humoral immune responses in both systemic and gut-mucosal compartments (Q43479731)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 2 October 2012

Language	Label	Description	Also known as
English	Intramuscular DNA immunization with in vivo electroporation induces antigen-specific cellular and humoral immune responses in both systemic and gut-mucosal compartments	scientific article published on 2 October 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Intramuscular DNA immunization with in vivo electroporation induces antigen-specific cellular and humoral immune responses in both systemic and gut-mucosal compartments (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

0 references

electroporation

1 reference

based on heuristic

inferred from title

Hiroyuki Mizuguchi

7

object named as

Hiroyuki Mizuguchi

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

author name string

Masaki Shoji

1

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Kazufumi Katayama

2

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Masashi Tachibana

3

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Kyoko Tomita

4

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Fuminori Sakurai

5

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Kenji Kawabata

6

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

language of work or name

0 references

publication date

2 October 2012

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

50

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

7278-7285

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Mucosal immunity and vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.046

7 January 2021

NALT- versus Peyer's-patch-mediated mucosal immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.046

7 January 2021

Public health. Grand Challenges in Global Health

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.046

7 January 2021

New generation of mucosal adjuvants for the induction of protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.046

7 January 2021

T-cell homing specificity and plasticity: new concepts and future challenges

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.046

7 January 2021

Mucosal vaccines: the promise and the challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.046

7 January 2021

Trafficking of antigen-specific CD8+ T lymphocytes to mucosal surfaces following intramuscular vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.046

7 January 2021

Route of adenovirus-based HIV-1 vaccine delivery impacts the phenotype and trafficking of vaccine-elicited CD8+ T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.046

7 January 2021

Long-lasting humoral and cellular immune responses and mucosal dissemination after intramuscular DNA immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.046

7 January 2021

A novel PPAR gamma gene therapy to control inflammation associated with inflammatory bowel disease in a murine model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.046

7 January 2021

Differential role of TLR- and RLR-signaling in the immune responses to influenza A virus infection and vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.046

7 January 2021

Immunogenic comparison of chimeric adenovirus 5/35 vector carrying optimized human immunodeficiency virus clade C genes and various promoters

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.046

7 January 2021

Role of beta7 integrins in intestinal lymphocyte homing and retention

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.046

7 January 2021

Intestinal and pulmonary mucosal T cells: local heroes fight to maintain the status quo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.046

7 January 2021

T-cell quality in memory and protection: implications for vaccine design

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.046

7 January 2021

Immunological commonalities and distinctions between airway and digestive immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.046

7 January 2021

Comparison of different routes of vaccination for eliciting antibody responses in the human stomach

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.046

7 January 2021

Retinoic acid imprints gut-homing specificity on T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.046

7 January 2021

GM-CSF and IL-4 synergistically trigger dendritic cells to acquire retinoic acid-producing capacity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.046

7 January 2021

Skin-draining lymph nodes contain dermis-derived CD103(-) dendritic cells that constitutively produce retinoic acid and induce Foxp3(+) regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.046

7 January 2021

PPD induced in vitro interferon gamma production is not a reliable correlate of protection against Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.046

7 January 2021

A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.046

7 January 2021

HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.046

7 January 2021

Prominent Role for Plasmacytoid Dendritic Cells in Mucosal T Cell-Independent IgA Induction

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.046

7 January 2021

TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.046

7 January 2021

Identifiers

10.1016/J.VACCINE.2012.09.046

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43479731&oldid=1989667436"